Easywell Biomedicals, Inc. (TPEX:1799)

Taiwan · Delayed Price · Currency is TWD

42.55

-0.95 (-2.18%)

Apr 20, 2026, 1:20 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Drug Development	597.41M	540.44M	271.63M	178.82M	191.97M
Drug Development Growth	10.54%	98.96%	51.90%	-6.85%	-27.40%
Other	-	-	-	79.00K	5.31M
Other Growth	-	-	-	-98.51%	64.80%
Total	597.41M	540.44M	271.63M	178.90M	197.28M
Total Growth	10.54%	98.96%	51.83%	-9.32%	-26.29%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
America	235.15M	326.15M	271.63M	178.82M	191.97M
America Growth	-27.90%	20.07%	51.90%	-6.85%	-3.25%
China	361.82M	214.17M	-	-	-
China Growth	68.94%	-	-	-	-
Taiwan	444.00K	119.00K	-	-	-
Taiwan Growth	273.11%	-	-	-	-
Mainland China	-	-	-	79.00K	-
Asia	-	-	-	-	5.31M
Asia Growth	-	-	-	-	-92.33%
Total	597.41M	540.44M	271.63M	178.90M	197.28M
Total Growth	10.54%	98.96%	51.83%	-9.32%	-26.29%

Source: S&P Global Market Intelligence.